Cardior Pharmaceuticals raised €64 million in Series B funding led by Inkef Capital. Biotech Health services Pharma Investments 25 August 2021 Share: Original story Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 76M Round investors: Bristol-Myers SquibbFundplusHigh-Tech GründerfondsCoparionInkef CapitalSunstone Life Science VenturesHadean VenturesLSP (Life Sciences Partners)BioMedPartnersEQT PartnersBoehringer Ingelheim Venture Fund Company: Cardior Pharmaceuticals Industry: BiotechHealth servicesPharma
Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden. Health services Pharma Investments 02 October 2025
NanoPhoria secured €83.5m in a series A w/ XGen Venture, Panakes Partner, Sofinnova Telethon, Sofinnova Partners, and Cdp Venture Capital. Biotech Health services Investments 01 October 2025
Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus Biotech Health services Manufacturing Pharma Software Services Investments 01 October 2025
MRM Health in a €55 million Series B financing round led by Biocodex, joined by Athos, BNP Paribas Fortis Private Equity, SFPIM, AvH, OMX, Qbic, VIB Health services Pharma Investments 01 September 2025
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds Biotech Health services Pharma Investments 01 September 2025